论文部分内容阅读
目的：：分析多巴胺联合硝普钠在老年顽固性心力衰竭患者治疗中应用的价值。方法：随机选取2014年1月至2015年12月我院收治的顽固性心力衰竭老年患者100例，采用随机数字表法将其分为研究组和对照组，每组50例。给予对照组常规治疗治疗，研究组在对照组的基础上使用多巴胺联合硝普钠治疗，观察两组患者的治疗总有效率以及LVD、心胸比、LVFS、LVEF等情况。结果：经治疗后，研究组患者总有效率92.00%明显高于对照组66.00%（P＜0.05）；两组患者LVD、心胸比治疗后较治疗前明显降低（P＜0.05），且研究组明显低于对照组（P＜0.05），两组患者LVFS、LVEF治疗后较治疗前明显增高（P＜0.05），且研究组明显高于对照组（P＜0.05）。结论：治疗顽固性心力衰竭，采用多巴胺联合硝普钠治疗效果更佳，值得临床应用。“,”Objective: to analyze the application of dopamine combined nitroprusside in the treatment of elderly patients with refractory heart failure in value. Methods: 100 elderly patients with refractory heart failure were randomly selected from January 2014 to December 2015 in our hospital were randomly divided into study group and control group, 50 cases in each group. The control group received routine the treatment, the study group used dopamine combined nitroprusside treatment on the basis of the control group, observe two groups of patients and the total efifciency of LVD, LVFS, LVEF and cardiothoracic ratio, etc. RESULTS: after the treatment, the total effective rate of study group 92% was signiifcantly higher than the control group 66% (P < 0.05); the two group LVD patients, cardiothoracic ratio after treatment was signiifcantly lower than before treatment (P < 0.05), and the study group was signiifcantly lower than the control group (P < 0.05), two groups of patients with LVFS after LVEF treatment was higher than before treatment (P < 0.05), and the study group Was signiifcantly higher than that of control group (P < 0.05). Conclusion: in the treatment of refractory heart failure, the dopamine combined nitroprusside therapy effect is better, it is worth clinical application.